AUTH/2839/4/16: Anonymous v Merck Sharp & Dohme — Diabetes nurses study day sponsorship (No breach) | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2839/4/16
Company	Merck Sharp & Dohme Limited
Complainant	Anonymous, non-contactable
Issue	Alleged lack of transparency about company involvement in a community diabetes nurses study day; alleged payment of speakers and that it was effectively a company meeting
Meeting	“Treat yourself – Boost your confidence in managing type II diabetes” (community diabetes nurses study day)
MSD involvement (as found)	Sponsorship of stand space only at fair market value; three local representatives attended to staff the stand; no role in organisation/content/speaker payment
Evidence referenced	Sponsorship letter/agreement stating payment for stand space; invitation/agenda listing sponsors (MSD one of several)
Clauses considered	2, 9.1, 9.10, 22.4
Decision	No breach of Clauses 2, 9.1, 9.10 and 22.4
Complaint received	18 April 2016 (PDF) / 19 April 2016 (web listing)
Case completed	10 May 2016
Appeal	No appeal
Applicable Code year	2016

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

An anonymous, non-contactable complainant raised concerns about Merck Sharp & Dohme’s (MSD) involvement in a study day for community diabetes nurses.
Allegation: all speakers were paid by MSD (estimated by the complainant at ~£8,000) and the agenda did not make clear it was “fundamentally” an MSD meeting.
Allegation: although it appeared organised by the local community diabetes nurses, it was actually organised by MSD.
MSD response: the event was conceived and run by the community diabetes nurses group as an independent third-party meeting; MSD sponsored stand space only at fair market value and did not organise the meeting, select speakers, or pay/brief speakers.
MSD provided a sponsorship agreement (signed 7 April 2016) instructing the organiser to declare MSD’s involvement on meeting materials; the invitation/agenda listed sponsors and showed MSD as one of several pharmaceutical sponsors.
The complainant provided no supporting evidence beyond the invitation/agenda and could not be contacted for further information.

⚖️

⌄

No breach of the Code was found.
The Panel found no evidence that MSD organised the meeting, paid speakers, or failed to be transparent about its involvement.
No breach was ruled for Clauses 2, 9.1, 9.10 and 22.4 (including no breach of Clause 2).

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access